Featured
Last news
South Korea's president begins move back to historic Blue House
South Korea's president and his team have started moving back into Seoul's historic Blue House, which his predecessor abandoned for being too "imperial", an official said Tuesday.
Data centers: a view from the inside
The expansion of data centers to power the AI boom has more people wondering: what exactly is in a data center?
Nextech3D.ai to Acquire Krafty Labs, Expanding AI Event Solutions for Enterprise Clients
Krafty Labs Generated 2025 Year to date Revenue of $1.1 mill with a 72% gross marginAll-Cash Deal for $600,000Acquiring a Blue Chip customers list; Google, Meta, Oracle etcNextech3d.ai Doubles Customer Base to 1000+Nextech3d.ai is Accelerating its Growth As a One-Stop AI Event Tech Suite
e& Selects Amdocs to Power Its Generative AI Experiences
Leveraging Amdocs' amAIz - generative AI Platform and its agents, powered by NVIDIA AI Enterprise, e& UAE is integrating generative AI into its business processes, opening possibilities for new revenue opportunities, business efficiencies, and improved customer experiences
Trump says to sign order blocking AI regulation by states
President Donald Trump said Monday he will attempt to strip states of the right to regulate the surging AI industry, arguing centralized rulemaking is vital to maintain US dominance.
AI tools help choose best embryos for IVF
Artificial intelligence tools can now help choose the most promising embryos for in vitro fertilisation (IVF), although experts have warned of some ethical concerns.
QNX to Showcase Innovations for Software-Defined Vehicles and Mission-Critical Embedded Systems at CES 2026
WATERLOO, ONTARIO / ACCESS Newswire / December 8, 2025 / QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB), has announced it will showcase the latest advancements in its mission-critical embedded systems and automotive software product portfolio, including a new demo of its Foundational Vehicle Software Platform developed in collaboration with Vector, at CES 2026.
Greenlane Buys $8 Million worth of BERA, Maintains Approximately $32 Million Cash and Stablecoin Reserves for Berachain Treasury Strategy
BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (Nasdaq:GNLN), a Berachain-focused digital asset treasury company and global seller of premium cannabis accessories, and subsequent to the Company's press releases issued on October 24, 2025 and November 14, 2025 that disclosed Greenlane's Berachain cryptocurrency treasury strategy (the "Berachain Treasury Strategy"), is providing an update on its BERA token holdings, staking activity, and capital position related to its participation in the Berachain ecosystem.
Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH
New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rateOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at ASH:95% of patients achieved rapid neutrophil recoveryMedian time to neutrophil recovery: 8 daysImmune recovery post-transplant was rapid94% disease-free and overall survivalNo cases of BMT-CTN severe acute graft-versus-host disease (GVHD), or chronic GVHD observedOmisirge approved by the FDA on December 5, 2025 for SAA
Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycleKey HighlightsMotixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a single apheresis session.Motixafortide alone and in combination with natalizumab mobilized 2.7 and 2.8 fold greater HSCs, relative to plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSCs for people with sickle cell disease enabling accelerated access to gene therapiesData from study shows that motixafortide was safe and well toleratedFindings presented at ASH 2025
Snaplii Reminds Shoppers of Special Cashback Offers During Holiday Season
It's the last call for the smart shopping app's holiday promotions, which provide increasing cashback rewards at spending milestones and offer double cashback rewards on select brands through Monday, Dec. 15.
Unusual Machines and Dynamic Aerospace Systems Enter Supplier Agreement for U.S.-Made, NDAA-Compliant Drone Components
Partnership supports DAS's expanding commercial logistics operations in the Middle East and Europe
Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies90% (9 of 10) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing86% (6 of 7) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease for gene therapiesFindings presented at ASH 2025
Meta partners with news outlets to expand AI content
Meta announced Friday it will integrate content from major news organizations into its artificial intelligence assistant to provide Facebook, Instagram and WhatsApp users with real-time information.
Softbank's Son says super AI could make humans like fish, win Nobel Prize
Softbank CEO and AI investor Masayoshi Son said Friday that advanced artificial intelligence could surpass humans to the extent that "we become fish" and could even win the Nobel Prize in Literature.
NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
QUEBEC, QC / ACCESS Newswire / December 5, 2025 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC:NRRWF)(FSE:1RN), a leading provider of mobile and broadband wireless infrastructure, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares ("Common Shares") on the basis of one post-consolidated Common Share for every three hundred (300) pre-consolidated Common Shares (the "Consolidation"). This Consolidation was approved by the Company's shareholders at the shareholders meeting held on October 22, 2025, where shareholder approval was given to undertake a consolidation of the Company's Common Shares at a ratio to be determined by the Board, at its sole discretion, to permit the Corporation to satisfy all conditions and necessary regulatory approvals to list the Common Shares on the NASDAQ, NYSE or such other U.S. national securities exchange as the Board may determine in its sole discretion.
FDA approves Omisirge(R) as First Approved Cell Therapy to Treat Severe Aplastic Anemia
Study demonstrated early and sustained hematopoietic recovery and transfusion independenceOmisirge is a new and novel transplant option for patients with SAAAdditional manufacturing capacity for Omisirge will be established in the U.S.Represents a supplementary FDA approval for Omisirge
EU hits Meta with antitrust probe over WhatsApp AI features
The EU said Thursday it has opened an antitrust probe to determine if the way Meta is rolling out AI features in WhatsApp breaches the bloc's competition rules.
In Turkey, ancient carved faces shed new light on Neolithic society
On the windswept hills overlooking Turkey's vast southeastern plains, new archaeological discoveries are revealing how life might have looked 11,000 years ago when the world's earliest communities began to emerge.
Tokenwell Expands Relationship with Talos for Crypto Basket Development
TORONTO, ON / ACCESS Newswire / December 4, 2025 / Tokenwell Platforms Inc. (CSE:TWEL)(OTCQB:TWELF)(FWB:Y920) ("Tokenwell" or the "Company"), is pleased to announce that it has expanded its relationship with Talos, a leading provider of institutional-grade crypto data and analytics, which acquired Coin Metrics earlier this year.
BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
WATERLOO, ONTARIO / ACCESS Newswire / December 4, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) will report results for the third quarter fiscal year 2026 at 5:30 p.m. ET on Thursday, December 18, 2025. The conference call can be accessed as a live webcast using the following link (here) or through the events section of the Company's investor webpage (BlackBerry.com/Investors) or by dialing toll free +1 (877) 883-0383 and entering Elite Entry Number 6312676.
Route1 Announces 2025 Annual General and Special Meeting Results
TORONTO, ON / ACCESS Newswire / December 4, 2025 / Route1 Inc. (TSXV:ROI) ("Route1" or the "Company"), a leading engineering and professional services firm specializing in the deployment and integration of advanced data capture-based technologies, and actionable business intelligence ("ABI") to city, state, and federal first responder departments, public safety and parking managers, today announced that it received approval for all of the proposals submitted to shareholders at the Company's annual general and special meeting of shareholders (the "Meeting"), which was held earlier today in Toronto, Canada.
Unusual Machines Announces Adjournment of Annual Meeting
Meeting scheduled to reconvene December 19, 2025, at 1:00 p.m. ET
ACCESS Newswire Announces up to $1 Million Dollar Share Repurchase Program
RALEIGH, NC / ACCESS Newswire / December 4, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS), an industry-leading communications company, today announced that its Board of Directors has approved an up to $1.0 million dollar share repurchase program of its common stock.
BEACN Closes First Tranche of Non-Brokered Private Placement
Not for distribution to United States Newswire Services or for dissemination in the United States
Satellite surge threatens space telescopes, astronomers warn
Light from the half a million satellites that humanity is planning to launch into Earth's orbit in the coming years could contaminate almost all the images taken by space telescopes, NASA astronomers warned Wednesday.
Women don fake mustaches in LinkedIn 'gender bias' fight
Flipping their gender setting to "male" and even posting photos with fake mustaches, a growing number of women on LinkedIn have posed a provocative challenge to what they allege is an algorithmic bias on the platform.
A2Z Cust2Mate Announces Agreement for Deployment of Smart Carts with a Leading Retailer in Central America
TORONTO, ON / ACCESS Newswire / December 3, 2025 / A2Z Cust2Mate Solutions Corp. (NASDAQ:AZ), a global leader in smart retail technology, today announced that it has entered into an agreement with a well established and highly regarded, premium grocery retailer with over 50 stores in Central America, to deploy the A2Z Cust2mate smart cart platform.
Blockchain Loyalty Corp. (OTC: BBLC) Provides Corporate Update On InfernoGrid AI Infrastructure Division And Koilink Fintech Platform
PORTLAND, OR / ACCESS Newswire / December 3, 2025 / Blockchain Loyalty Corp. (OTC:BBLC) (the "Company" or "BBLC") is pleased to provide a corporate update on its technology strategy, highlighting progress on its AI infrastructure division, InfernoGrid, and its fintech platform, Koilink Technologies Inc.
OMP's AI-driven Unison Planning(TM) Platform Enhances Supply Chain Agility for McCormick & Co.
The initiative tackles key challenges, including balancing ATO and MTS production on shared lines, improving inventory projections through quality-based stock releases, and managing capacity amid fluctuating demand. Addressing these challenges requires close collaboration across regions with North American and EMEA teams working in parallel, and seamless integration of SAP with the operational planning functionality within Unison Planning™. The first implementations will roll out in Canada and the United States before expanding to the EMEA and APAC regions.
Biomind Labs Accelerates FDA Pathway for 5-MEO-DMT Candidate BMND08 with Proprietary Nano-Formulation as Patent Observations Are Successfully Withstood
BIOMIND LABS ACCELERATES FDA PATHWAY FOR 5-MEO-DMT CANDIDATE BMND08 AND GRANTS STOCK OPTIONS
ShelfieTech Ltd. Announces Closing of Private Placement
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / December 3, 2025 / ShelfieTech Ltd. (CSE:SHLF)(OTCQB:SHLFF) ("Shelfie", or the "Company") is pleased to announce that, further to its news releases of November 6, 2025 , it has closed the non-brokered private placement (the "Private Placement") raising gross proceeds of $1,699,185 through the issuance of 1,179,990 common shares in the capital of the Company (each a "Share") at a price of $1.44 per Share.